• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓扑异构酶IIβ抑制剂XK469通过多种途径诱导华氏巨球蛋白血症细胞凋亡。

XK469, a topo IIbeta inhibitor, induces apoptosis in Waldenstrom's macroglobulinemia through multiple pathways.

作者信息

Mensah-Osman Edith, Al-Katib Ayad, Dandashi Mahmoud, Mohammad Ramzi

机构信息

Division of Hematology and Oncology, Department of Internal Medicine, Karmanos Cancer Institute at Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

Int J Oncol. 2003 Dec;23(6):1637-44.

PMID:14612935
Abstract

We have previously reported that XK469 inhibited topoisomerase (topo) IIbeta, in Waldenstrom's macroglobulinemia cell line (WSU-WM) however the inhibition alone is not sufficient to induce apoptosis. In this study, the apoptotic potential of XK469 and its mechanism in WSU-WM cell line was investigated. Exposure of WSU-WM cells to XK469 caused a decrease in viable cell number in a dose-dependent manner. In addition, XK469 caused the activation of caspase 3 resulting in subsequent cleavage of PARP. These events were preceded by the release of cytochrome c from the mitochondria to the cytosol. Simultaneous exposure of cells to cyclosporin A prevented the release of cytochrome c to cytosol and reduced the loss of viability. XK469 caused the activation of p53 with up-regulation of p53-dependent proteins such as Bax, p21, Gadd 45 and cyclin B1 in association with G2M arrest. The addition of ubiquitin carboxyl terminal hydrolase (UCH-L1) inhibitor (NaBH4) inhibited up-regulation of p53 and p53 related molecules by XK469 and reduced the loss of viability. Pre-incubation with NOK-1, a monoclonal antibody that prevents Fas-Fas ligand interaction and is inhibitory to Fas signaling interfered with XK469 induced activation of caspase 8 and also reduced the loss of viability. Simultaneous exposure of all three inhibitors (cyclosporin A, NaBH4 and NOK-1) abrogated the toxicity of XK469 by 95%. These data define multiple sequences of biochemical events that mediate cell death induced by XK469. Our study suggests a complex mechanistic cascade of XK469-mediated apoptosis that involves Fas signaling pathway, ubiquitination, p53 activation and cytochrome c release.

摘要

我们之前报道过,XK469可抑制华氏巨球蛋白血症细胞系(WSU-WM)中的拓扑异构酶(topo)IIβ,然而单纯的抑制作用并不足以诱导细胞凋亡。在本研究中,我们对XK469在WSU-WM细胞系中的凋亡潜力及其机制进行了研究。将WSU-WM细胞暴露于XK469会导致活细胞数量呈剂量依赖性减少。此外,XK469会导致半胱天冬酶3激活,进而导致聚(ADP-核糖)聚合酶(PARP)随后被切割。这些事件之前有线粒体中的细胞色素c释放到细胞质中。细胞同时暴露于环孢素A可阻止细胞色素c释放到细胞质中,并减少细胞活力丧失。XK469导致p53激活,同时上调p53依赖性蛋白,如Bax、p21、生长停滞和DNA损伤诱导蛋白45(Gadd 45)以及细胞周期蛋白B1,并伴有G2/M期阻滞。添加泛素羧基末端水解酶(UCH-L1)抑制剂(NaBH4)可抑制XK469对p53及其相关分子的上调作用,并减少细胞活力丧失。用NOK-1(一种可阻止Fas-Fas配体相互作用并抑制Fas信号传导的单克隆抗体)预孵育会干扰XK469诱导的半胱天冬酶8激活,也会减少细胞活力丧失。同时暴露于所有三种抑制剂(环孢素A、NaBH4和NOK-1)可消除XK469 95%的毒性。这些数据确定了介导XK469诱导细胞死亡的多个生化事件序列。我们的研究表明,XK469介导的凋亡涉及一个复杂的机制级联反应,包括Fas信号通路、泛素化、p53激活和细胞色素c释放。

相似文献

1
XK469, a topo IIbeta inhibitor, induces apoptosis in Waldenstrom's macroglobulinemia through multiple pathways.拓扑异构酶IIβ抑制剂XK469通过多种途径诱导华氏巨球蛋白血症细胞凋亡。
Int J Oncol. 2003 Dec;23(6):1637-44.
2
2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid (XK469) inhibition of topoisomerase IIbeta is not sufficient for therapeutic response in human Waldenstrom's macroglobulinemia xenograft model.2-[4-(7-氯-2-喹喔啉氧基)苯氧基]-丙酸(XK469)对拓扑异构酶IIβ的抑制作用不足以在人瓦尔登斯特伦巨球蛋白血症异种移植模型中产生治疗反应。
Mol Cancer Ther. 2002 Dec;1(14):1315-20.
3
2-[4-(7-chloro-2-quinoxalinyloxyphenoxy]-propionic acid (XK469), an inhibitor of topoisomerase (Topo) IIbeta, up-regulates Topo IIalpha and enhances Topo IIalpha-mediated cytotoxicity.2-[4-(7-氯-2-喹喔啉基氧基)苯氧基]丙酸(XK469),一种拓扑异构酶(Topo)IIβ抑制剂,可上调Topo IIα并增强Topo IIα介导的细胞毒性。
Mol Cancer Ther. 2002 Dec;1(14):1321-6.
4
Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells.放线菌素,一种组蛋白去乙酰化酶抑制剂,可诱导人急性早幼粒细胞白血病细胞凋亡并促进Fas/Fas配体表达。
J Biol Chem. 2002 Jan 18;277(3):2073-80. doi: 10.1074/jbc.M106699200. Epub 2001 Nov 6.
5
Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.合成的1,4 - 蒽二酮类似物通过一种涉及半胱天冬酶 - 2激活但不涉及Fas信号传导的机制,诱导HL - 60细胞中的细胞色素c释放、半胱天冬酶 - 9、 - 3和 - 8活性、聚(ADP - 核糖)聚合酶 - 1裂解以及核小体间DNA片段化。
Biochem Pharmacol. 2004 Feb 1;67(3):523-37. doi: 10.1016/j.bcp.2003.09.012.
6
Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.组蛋白脱乙酰酶抑制剂阿皮西丁通过激活人Bcr-Abl阳性白血病细胞中依赖线粒体的半胱天冬酶级联反应诱导细胞凋亡。
Clin Cancer Res. 2003 Oct 15;9(13):5018-27.
7
Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.癌栓素 - A4前药在慢性淋巴细胞白血病细胞系中诱导有丝分裂灾难,与半胱天冬酶激活和聚(ADP - 核糖)聚合酶裂解无关。
Clin Cancer Res. 2002 Aug;8(8):2735-41.
8
Taxol induces caspase-10-dependent apoptosis.紫杉醇诱导半胱天冬酶-10依赖性凋亡。
J Biol Chem. 2004 Dec 3;279(49):51057-67. doi: 10.1074/jbc.M406543200. Epub 2004 Sep 27.
9
Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells.波希鼠李糖醛酸通过一条依赖于半胱天冬酶-8激活但独立于Fas/Fas配体相互作用的途径在结肠癌HT-29细胞中触发细胞凋亡。
Carcinogenesis. 2002 Dec;23(12):2087-93. doi: 10.1093/carcin/23.12.2087.
10
Induction of apoptosis by the new anticancer drug XK469 in human ovarian cancer cell lines.新型抗癌药物XK469对人卵巢癌细胞系凋亡的诱导作用。
Oncogene. 2002 Jul 4;21(29):4530-8. doi: 10.1038/sj.onc.1205545.

引用本文的文献

1
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II in Human Leukemia K562 Cells: Generation of a Resistance Phenotype.利用 CRISPR/Cas9 同源定向修复技术对人白血病 K562 细胞的拓扑异构酶 II 进行基因编辑:耐药表型的产生。
J Pharmacol Exp Ther. 2024 Apr 18;389(2):186-196. doi: 10.1124/jpet.123.002038.
2
Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase II Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide.人白血病 K562 细胞对依托泊苷获得性耐药中 hsa-miR-9-3p 和 hsa-miR-9-5p 对拓扑异构酶 II 表达的影响。
J Pharmacol Exp Ther. 2023 Feb;384(2):265-276. doi: 10.1124/jpet.122.001429. Epub 2022 Nov 21.
3
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
喹喔啉类抗肿瘤剂(R+)XK469 抑制神经母细胞瘤肿瘤生长。
Pediatr Blood Cancer. 2011 Jan;56(1):164-7. doi: 10.1002/pbc.22639.
4
The chemotherapeutic agents XK469 (2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid) and SH80 (2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid) inhibit cytokinesis and promote polyploidy and induce senescence.化疗药物XK469(2-{4-[(7-氯-2-喹喔啉基)氧基]苯氧基}丙酸)和SH80(2-{4-[(7-溴-2-喹啉基)氧基]苯氧基}丙酸)可抑制胞质分裂,促进多倍体形成并诱导衰老。
J Pharmacol Exp Ther. 2009 Mar;328(3):796-806. doi: 10.1124/jpet.108.144808. Epub 2008 Dec 9.
5
The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80.自噬在新型抗肿瘤药物XK469和SH80引发的L1210白血病细胞死亡中的作用
Mol Cancer Ther. 2007 Jan;6(1):370-9. doi: 10.1158/1535-7163.MCT-05-0386.